Eight Roads is a global venture capital firm, established in 1969, that invests in technology and healthcare companies across Asia, Europe, Israel, and the United States. It manages over $11 billion in assets through various funds, including Eight Roads Ventures China, Europe, India, and Japan. The firm focuses on early venture, growth capital, and growth stage investments, typically committing between $1.29 million to $30 million per company. Eight Roads seeks minority and majority stakes, often taking a board seat, and has invested in over 500 companies such as Alibaba, Chewy, and Toast. It operates as the proprietary investment arm of Fidelity International Limited.
Managing Partner, Fidelity International Strategic Ventures
Umang Agarwal
Principal
Sanjay Aggarwal
Venture Partner
Hiroki Ashida
Vice President
Daniel Auerbach
Senior Managing Partner, Asia
Vytautas Balsys
Partner
Helena Barman
Investor
Virginia Bassano
Vice President
Shirish Belapure
Venture Partner
Daniel Benjamin
Associate
Bhushan Bopardikar
Vice President
Betty Cai
Partner
Arvind Chari
Vice President
Ted Chua
Partner
Lucile Cornet
Partner
Kevin Du
Senior Associate
Raj Dugar
Managing Partner, Asia
Martin Ericsson
Principal
Tamina Fogelberg
Associate
Siddhant Gandhi
Associate
Elaine Gao
Senior Associate
Antonin Gury-Coupier
Vice President
Davor Hebel
Managing Partner and Head of Europe
April Hu
Vice President
Tao Huang
Principal
Tammy Huang
Senior Associate
Tao Huang
Principal
Allen Huo
Vice President
Abhishek Jain
Vice President
Zang Jialun
Partner
Murata Junichi
Principal
Deepak Kanvinde
Venture Partner
Michiko Kohyama
Vice President
Shinichiro Komoto
Partner
Kavish Kothari
Principal
Chintan Kothari
Partner
Thomas Lin
Vice President
Rebecca Lin
Partner
Xin Liu
Partner
Allen Liu
Senior Associate
Maneesh Menon
Principal
Sophie Meralli
Vice President
Chersy Miao
Senior Associate
David Milstein
Managing Partner and Head of Japan
Jens Neisius
Vice President
Dan O'Toole
Vice President
Yosuke Ouchi
Principal
Delphine Qiu
Principal
Eyal Rabinovich
Principal
Laura Salesse
Senior Associate
Fuga Sawada
Senior Associate
Shawn Shen
Partner
Sagar Sheth
Vice President
Lei Shi Ph.D
Partner
Arjun Singh
Senior Associate
Michael Stephanblome
Venture Partner
Liena Suzuki MD
Principal
Aditya Gurunath Systla
Principal
Michael Treskow
Partner
Jarlon Tsang
Managing Partner and Head of China
Ashish Venkataramani
Partner
Ashish Venkataramani
Partner
He Wang
Vice President
Bo Wang
Senior Associate
Nancy Xu
Vice President
Cody Yin Ph.D
Partner
Zhang Yixiao
Executive Director
Yuan Yuan
Principal
Alston Zecha
FinTech and Enterprise Software and Director
Haoming Zhang
Vice President
Gordon Zhang
Vice President and Principal
Feng Zhao
Partner
Weimin Liu Ph.D
Partner
581 past transactions
UGOKU
Series B in 2025
UGOKU is a provider of management of personal coaching service.
Salowin
Series D in 2025
SALOWIN Inc. is a beauty salon company based in Tokyo, Japan, that specializes in providing shared salon services for beauticians. Founded in 2019, SALOWIN offers private room share salons equipped with comprehensive facilities to support beauty professionals. The company facilitates a full support system, including prepayment options for sales, which enables hairdressers to enhance their income potential. By helping beauticians to operate within a shared environment, SALOWIN fosters a collaborative atmosphere while allowing professionals to benefit from well-equipped spaces.
Swan
Series B in 2025
Swan is a European fintech company that specializes in embedded finance, providing an online banking platform for businesses to create and manage their bank accounts. Founded in 2019 and based in Paris, Swan enables companies to integrate banking features, such as accounts, cards, and payments, into their own products through simple APIs. The platform processes over 200 million euros in transactions monthly for more than 60 companies across ten European countries. As a licensed financial institution and a principal member of Mastercard, Swan is regulated by the ACPR. The company was co-founded with the startup studio eFounders and has received growth capital from prominent venture capital investors. Swan is led by a team of fintech experts with extensive industry experience.
Eleos Health
Series C in 2025
Eleos Health develops innovative health technology solutions aimed at enhancing decision-making for clinicians in the behavioral health sector. The company's AI-powered Speech-to-Insights system operates during mental health sessions to analyze voice data in real time. By gathering insights on patients through this voice technology, Eleos Health enables clinicians to deliver personalized, efficient, and cost-effective care. The automated nature of the system helps streamline the clinical process, ultimately supporting mental health professionals in providing the necessary care and support for their patients.
Beads
Series A in 2025
Beads is a hospice housing organisation that provides hospice housing and independent living facility.
Tenpoint Therapeutics
Venture Round in 2024
Tenpoint Therapeutics is a biotechnology company dedicated to developing engineered cell-based therapies aimed at restoring vision for individuals affected by degenerative ocular diseases. The company leverages an innovative platform that includes in vivo reprogramming techniques, allowing for targeted delivery of therapeutic systems directly to the eye. This approach eliminates the need for systemic administration, which can improve treatment efficacy and patient outcomes. By focusing on vision restoration, Tenpoint Therapeutics strives to significantly enhance the quality of life for patients suffering from various eye conditions.
Laurus Bio
Venture Round in 2024
Laurus Bio specializes in precision fermentation, providing expertise to clients involved in microbial fermentation-based manufacturing and product development. The company focuses on the production of animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements. Their offerings cater to various sectors, including cultured meat, biologics, vaccine development, and regenerative medicine. By developing novel non-animal origin proteins and media components, Laurus Bio aims to enhance safety, consistency, and traceability in the pharmaceutical and bio-manufacturing industries, enabling clients to create greener and more sustainable healthcare products.
Lighthouse
Series C in 2024
Lighthouse is a commercial platform tailored for the travel and hospitality industry, specializing in hotel management solutions. The company offers a cloud-based platform that visualizes and leverages data to enhance business success. By providing actionable market insights and business intelligence tools, Lighthouse enables hoteliers and hotel management companies to make informed revenue and distribution decisions. Its services include real-time data analytics, which empower users to maximize property occupancy rates and increase revenue and profit. Formerly known as OTA Insight, Lighthouse aims to transform complex market dynamics into manageable strategies that foster growth in the hospitality sector.
Bhanzu
Series B in 2024
Bhanzu is a math-learning platform aimed at fostering interest in math and STEM careers among students of all ages. The platform offers a carefully crafted curriculum that caters to individual learning needs, ensuring a customized educational experience. Bhanzu provides a variety of educational resources, including videos that address common challenges such as math anxiety, particularly for younger learners in grades 1 to 3. By promoting experiential learning and enhancing cognitive abilities, Bhanzu helps students improve their math skills and apply mathematical concepts in real-world situations.
Dingzhi Dental
Series A in 2024
Dingzhi Dental is a dental institution service provider that specializes in dental medical chain management, institutional investment, medical education, and supply chain, as well as dental institution franchising and discipline co-construction.
AvenCell
Series B in 2024
Based on our deep science and focused on patients in need.
Everstage
Series B in 2024
Everstage is a no-code commissions automation platform founded in 2020 and based in Wilmington, Delaware. The company focuses on enhancing the performance of customer-facing teams by providing a transparent and gamified incentives experience. Its platform allows businesses to create customized incentive structures while automating repetitive manual tasks. With features that offer real-time visibility and insights into performance, Everstage aims to save Operations and Finance teams time and effort, ultimately motivating employees and driving productivity.
Spry
Series B in 2024
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.
Fat Fee
Series A in 2024
Fat Fee is a health food supplier, mainly engaged in the healthy upgrading of oils and the development and application of fat replacement technology based on bio-oil refining technology, and has launched a series of edible oil products.
HERO Software
Series B in 2024
HERO Software specializes in cloud-based solutions that enhance office productivity and streamline project management processes for businesses. Its comprehensive platform enables users to digitize the entire workflow, starting from initial client interactions through to invoicing. The HERO application offers a range of features tailored for professionals in the field, including customer and project management, appointment scheduling, construction site documentation, and task management. By facilitating effective communication and improving operational management, HERO Software supports various aspects of a craftsman's operations, allowing for better monitoring of project progress and task completion.
Canoe
Series C in 2024
Canoe Software Inc. provides a sophisticated software solution focused on financial document and data management. Founded in 2013 and based in New York, the company specializes in automating the extraction and organization of investment documents using artificial intelligence and machine learning technologies. This enables users to efficiently convert unstructured data from various formats, such as PDFs, into actionable insights, thereby improving operational efficiency. Canoe's platform supports a wide range of clients, including single and multi-family offices, endowments, foundations, pensions, investment consultants, and financial institutions, facilitating better management of post-investment operations, monitoring, and reporting. By streamlining the data management process, Canoe helps minimize manual data entry and enhances the accuracy of financial reporting and analysis.
Odaseva
Series C in 2024
Odaseva is a company that specializes in data management solutions for large enterprises using Salesforce. Its platform provides comprehensive data governance that focuses on data protection, privacy, and operational efficiency. Key features include backup and recovery, archiving, monitoring of governor limits, and compliance with regulatory requirements such as GDPR. Odaseva's tools enable businesses to manage their Salesforce data effectively, ensuring its confidentiality, integrity, and availability. By offering a range of integrated security products and services, Odaseva empowers organizations to take full control of their data, mitigate risks, and accelerate their digital transformation initiatives.
Fibe
Secondary Market in 2024
Fibe is a prominent consumer lending application in India, catering to the financial needs of young, aspirational, and tech-savvy individuals. The company has developed an online financial platform that specializes in providing ultra short-term loans and salary advances. Its services include small bridge loans that assist customers until their next salary credit, as well as small loans designed to help users navigate financial challenges at the end of the month. By offering accessible and timely financial solutions, Fibe aims to support users during critical times, making it a valuable resource for managing immediate credit needs.
Fibe
Series E in 2024
Fibe is a prominent consumer lending application in India, catering to the financial needs of young, aspirational, and tech-savvy individuals. The company has developed an online financial platform that specializes in providing ultra short-term loans and salary advances. Its services include small bridge loans that assist customers until their next salary credit, as well as small loans designed to help users navigate financial challenges at the end of the month. By offering accessible and timely financial solutions, Fibe aims to support users during critical times, making it a valuable resource for managing immediate credit needs.
Arnatar Therapeutics
Series A in 2024
Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
Pelago
Series C in 2024
Pelago, formerly known as Quit Genius, is a leading virtual clinic focused on substance use management, particularly for tobacco, alcohol, and opioids. The company aims to transform support for substance use by offering education, management skills, and opportunities for positive change to individuals struggling with addiction. Pelago provides employers with a means to offer on-demand, personalized support for employees seeking healthier lifestyles. Its platform utilizes cognitive behavioral therapy (CBT) to address the psychological aspects of addiction, helping users identify triggers and access support through animated videos, interactive exercises, and audio sessions. This approach allows individuals to work at their own pace with the assistance of a personalized coach. Pelago's services seamlessly integrate with health plans, pharmacy benefit managers, and wellness platforms, and the company has successfully supported over 750,000 members in managing their substance use and improving their overall well-being.
Engrail Therapeutics
Series B in 2024
Engrail Therapeutics, Inc. is dedicated to developing and commercializing neuro drugs aimed at treating diseases of the nervous system. Founded in 2019 and based in San Diego, California, the company focuses on creating transformative medicines to alleviate the significant burden of such conditions. One of its key products is ENX-101, a preclinical compound designed to modulate a receptor for GABA, a critical neurotransmitter in the brain. Engrail Therapeutics combines biological insights with clinically meaningful solutions to advance its portfolio of therapies, utilizing a flexible transaction model to efficiently progress its drug candidates from development to commercialization.
HiLabs
Series B in 2024
HiLabs is a developer of a healthcare data mining platform that aims to enhance data-driven decision-making within healthcare organizations. Recognizing that these organizations possess invaluable domain knowledge, HiLabs provides tools that enable them to harness this expertise alongside their data. The platform employs artificial intelligence to allow healthcare professionals to intuitively explore their data, interact with visualizations, customize dashboards, and generate new attributes. This empowers users to independently uncover novel insights and better understand client health data, ultimately facilitating more effective healthcare management and decision-making.
Shadowfax
Series E in 2024
Shadowfax is an on-demand logistics network that specializes in providing tech-enabled delivery solutions across various sectors, including e-commerce, food, pharmacy, and consumer goods. By leveraging its unique app, the company offers a reliable last-mile delivery service, allowing businesses to concentrate on their core operations while outsourcing their delivery needs. Shadowfax aims to enhance the customer experience through efficient, fast, and dependable delivery options. Its platform serves both online and offline retailers, catering to the diverse logistics demands of merchants and ensuring timely service. The company envisions establishing itself as a trustworthy and desirable delivery platform, emphasizing the use of advanced technology to streamline logistics and improve customer satisfaction.
EurekaBio
Series B in 2024
EurekaBio specializes in developing solutions for cancer immunotherapy, particularly in the realm of cell therapy. The company offers automated manufacturing equipment for cell therapies and a platform for vector production. By focusing on automation in medical equipment related to gene and cell therapy, EurekaBio aims to enhance the accuracy and efficiency of cancer treatments, ultimately benefiting patients in need of innovative therapeutic options.
Newmo
Seed Round in 2024
newmo delivers sustainable local public transportation create a user experience (UX) that people may utilize with peace of mind and comfort.
OpenLogi
Series D in 2024
OpenLogi Inc. is a Tokyo-based logistics platform established in December 2013, designed specifically for small and medium-sized enterprises (SMEs) and freelancers. The company offers an outsourced logistics solution that includes features such as warehouse inspection, storage, shipping, and management of returned merchandise, all accessible through a user-friendly dashboard. By leveraging unused warehouse assets and optimizing logistics operations, OpenLogi provides affordable rates and innovative technology to streamline warehouse control systems. Founded by Hidetsugu Ito, who previously worked on the Japanese magazine subscription service Fujisan.co.jp, OpenLogi aims to address the logistics challenges faced by small e-commerce businesses in Japan.
La Fourche
Series B in 2024
La Fourche is an online retail platform dedicated to making healthy consumption accessible to a broader audience by offering a wide range of organic products at affordable prices. The company operates on a subscription model, providing customers with thousands of organic items at discounts of up to 50%. This approach allows families to significantly reduce their grocery spending, potentially saving up to 1,000 euros annually. La Fourche emphasizes the importance of socially committed and environmentally friendly options, enabling consumers to select from a diverse array of healthy food products while promoting sustainable practices.
Xbit
Venture Round in 2024
Xbit provides a shift management system that assists shop owners in optimizing their business processes. The company's platform includes a chatbot service that enables users to gather employee availability and create efficient shift schedules. By addressing customer needs and implementing effective solutions, Xbit helps clients reduce operational costs while maintaining service quality through proper personnel allocation.
makeO
Series D in 2024
makeO is a developer of an innovative oral and skin care platform that allows individuals to attain their desired smile and complexion. The company offers a range of at-home solutions, including invisible aligners for teeth straightening, products for teeth whitening, and skin rejuvenation treatments such as laser hair removal and scientifically formulated skincare products. By providing these accessible options, makeO empowers customers to manage their beauty journeys conveniently and effectively.
Everheal
Venture Round in 2024
Everheal is a health-tech startup focused on providing comprehensive support for women during the pre-conception, pregnancy, and post-partum periods. The company operates a maternity care platform that serves as an all-in-one resource for mothers. It offers gynecologists tools to enhance clinical outcomes and generate revenue through various patient support features. These include tech-assisted service packages, an e-store, and monitoring devices that facilitate nutrition tracking, video consultations, and automated vital sign monitoring for patients dealing with gestational diabetes or hypertension. By integrating multiple healthcare services into a single platform, Everheal aims to streamline the maternal care experience and improve health outcomes for women.
Eon
Seed Round in 2024
Eon is an enterprise backup and recovery solution that uses automatic mapping and classification to ensure that only essential data is stored. The EON platform is designed to enhance operational excellence through cloud-based software that implements improvements, develops capabilities, and measures results effectively. The company focuses on backup posture management, helping businesses classify and index their cloud resources efficiently, ensuring that essential data is prioritized in storage.
Micoworks
Series B in 2023
Micoworks is a planning and development platform that focuses on enhancing marketing strategies through improved communication. It offers tools designed for optimal communication and personalization of the customer experience. The platform enables businesses to categorize customer information effectively and automates various processes, including customer interviews, conversations, and reservations. This functionality allows clients to streamline their operations and develop their marketing strategies more efficiently.
PlasmaGen Biosciences
Venture Round in 2023
PlasmaGen Biosciences Pvt. Ltd. is an Indian bio-pharmaceutical company based in Bengaluru, specializing in the manufacture of plasma-derived products and therapies. Established in 2010, the company develops a range of plasma protein therapies, including PlasmaGlob and AlbuMax, which are Normal Human Immunoglobulin formulations for intravenous use. Their product portfolio also includes PlasmaRho-D I.V. for Rho (D) immunization, PlasmaRAB for rabies post-exposure prophylaxis, and PlasmaHep for various hepatitis B-related indications. Additionally, PlasmaGen offers VerBumin for conditions such as hypovolemic shock and plasma exchange dialysis. The company serves a diverse clientele, including clinicians, medical practitioners, corporate hospitals, and government institutions, positioning itself as a key provider of plasma products across various medical fields, including hematology, oncology, and immunology.
Exponent Energy
Series B in 2023
Exponent Energy is a start-up dedicated to enhancing electric vehicle (EV) charging through innovative fast charging technology. The company specializes in battery-swapping infrastructure, aiming to provide a more efficient and cost-effective charging solution for EV users. It manufactures an integrated energy stack designed to minimize impedance build-up, which facilitates a smooth energy flow. This system includes a cohesive battery management system, battery pack, and charger that work in unison to streamline the charging process. By focusing on these advancements, Exponent Energy seeks to simplify and accelerate the energy replenishment for electric vehicles, catering to the growing demand for sustainable transportation solutions.
Shinobi Therapeutics
Series A in 2023
Shinobi Therapeutics specializes in the development of cell therapies that leverage hypoimmune CD8αβ iPS-T cells to interact with the immune system for the treatment of cancer and various genetic diseases. The company's innovative approach incorporates advanced immune evasion technology to enhance the effectiveness and accessibility of these therapies. By focusing on durable responses and the potential for redosing, Shinobi aims to reduce costs and improve patient outcomes in the healthcare sector.
Eleos Health
Series B in 2023
Eleos Health develops innovative health technology solutions aimed at enhancing decision-making for clinicians in the behavioral health sector. The company's AI-powered Speech-to-Insights system operates during mental health sessions to analyze voice data in real time. By gathering insights on patients through this voice technology, Eleos Health enables clinicians to deliver personalized, efficient, and cost-effective care. The automated nature of the system helps streamline the clinical process, ultimately supporting mental health professionals in providing the necessary care and support for their patients.
Sonosemi Medical
Series B in 2023
Sonosemi Medical is a provider of medical devices that specializes in the development of pan-vascular active interventional products, diagnosis, and treatment solutions.
La Fourche
Series B in 2023
La Fourche is an online retail platform dedicated to making healthy consumption accessible to a broader audience by offering a wide range of organic products at affordable prices. The company operates on a subscription model, providing customers with thousands of organic items at discounts of up to 50%. This approach allows families to significantly reduce their grocery spending, potentially saving up to 1,000 euros annually. La Fourche emphasizes the importance of socially committed and environmentally friendly options, enabling consumers to select from a diverse array of healthy food products while promoting sustainable practices.
AlphaGen Therapeutics
Seed Round in 2023
AlphaGen Therapeutics is a biotechnology company that focuses on innovative radioligand therapies for cancer treatments.
Pixocial
Series A in 2023
Pixocial is a software company that provides beauty and creative solutions for consumers, small businesses, and enterprise clients. They provide creative and retouching editing experiences for social media and creators.
ScyllaDB
Series C in 2023
ScyllaDB is a company specializing in the development of high-performance, scalable column store database software, particularly suited for data-intensive applications. It offers both open-source and enterprise versions of its product, which can be deployed in various environments, alongside ScyllaDB Cloud, a fully-managed Database as a Service available on major cloud platforms like AWS and Google Cloud. The software is designed to support wide-column NoSQL workloads and is fully compatible with popular systems such as Apache Cassandra and Amazon DynamoDB. Founded as Cloudius Systems, ScyllaDB is based in Herzliya, Israel, and aims to deliver exceptional performance and low latency while reducing costs, enabling organizations to leverage modern multi-core servers effectively as their data needs evolve.
Doceree
Series B in 2023
Doceree Inc is a healthcare marketing technology company that operates a programmatic physician engagement and advertising platform. Founded in 2019 and based in Parsippany, New Jersey, with an additional office in New Delhi, India, Doceree specializes in connecting pharmaceutical and healthcare brands with healthcare professionals (HCPs). The platform enables targeted advertising and provides data analytics to help clients effectively reach and engage with HCPs in a compliant manner. Utilizing artificial intelligence and data segmentation, Doceree identifies specific HCPs across various digital platforms, including physician networking sites, medical journals, and telemedicine platforms. This approach allows healthcare industry professionals to deliver precise and transparent messaging at scale, catering to the needs of media agencies, pharmaceutical brands, medical device companies, consumer healthcare brands, and hospitals.
Cataya Bio
Series B in 2023
Cataya Bio (Shanghai) Co., Ltd. is focused on developing synthetic biological products for diverse industries through its advanced engineering biology platform and biomanufacturing capabilities. The company engineers microbes and creates clean fermentation processes to produce high-purity products sustainably and cost-effectively. By leveraging synthetic biology technology, Cataya Bio enables clients to obtain natural and sustainable raw materials, contributing to a shift away from petroleum-based resources. The company's efforts address critical global challenges such as environmental preservation, carbon emissions, and climate change.
New Vision Medical
Series A in 2023
New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
Tenpoint Therapeutics
Series A in 2023
Tenpoint Therapeutics is a biotechnology company dedicated to developing engineered cell-based therapies aimed at restoring vision for individuals affected by degenerative ocular diseases. The company leverages an innovative platform that includes in vivo reprogramming techniques, allowing for targeted delivery of therapeutic systems directly to the eye. This approach eliminates the need for systemic administration, which can improve treatment efficacy and patient outcomes. By focusing on vision restoration, Tenpoint Therapeutics strives to significantly enhance the quality of life for patients suffering from various eye conditions.
Raft
Series B in 2023
Raft is a logistics platform that leverages artificial intelligence to automate the freight process, providing enhanced control and visibility for operators. By streamlining various tasks such as managing accounts payable invoices, customs documentation, and shipping workflows, Raft significantly reduces the need for manual input and reconciliation. This automation allows freight forwarders and customs brokers to operate more efficiently, saving valuable time and improving accuracy and compliance in their operations. The platform's real-time processing capabilities enable operators to handle shipments promptly and with greater certainty, ultimately enhancing customer service.
Chian Technology
Venture Round in 2023
Chian Technology is a developer of a network security system. The company's product line includes standardized zero-trust products as well as customized zero-trust solutions based on the personalized circumstances of various customers, allowing users to obtain multi-faceted network security protection. Their products are used in fields such as the Internet, finance, energy, technology, high-end manufacturing, new retail, and others.
K36 Therapeutics
Series B in 2023
K36 Therapeutics is engaged in the development of small molecule therapeutics aimed at treating cancer. The company focuses on translating epigenetic modulation of oncogenic pathways into effective therapies, utilizing technology to create orally bioavailable small molecules and selective inhibitors. This innovative approach enables healthcare professionals to enhance treatment options for cancer patients, addressing the complexities of oncogenic pathways and improving therapeutic outcomes.
BTP Automation
Grant in 2023
BTP Automation specializes in optimizing corporate travel through its advanced hotel sourcing management platform. The company collects and analyzes hotel data from various sources to identify automated cost-saving opportunities. Its technology provides travel buyers with real-time insights into key performance indicators, enhancing the management of hotel programs. By streamlining processes and offering strategic hotel management solutions, BTP Automation enables clients to maximize the value of their travel programs while gaining deeper insights into hotel attachment rates. This focus on business intelligence and analytics helps organizations improve their overall travel efficiency and cost-effectiveness.
Adcentrx Therapeutics
Series A in 2023
Adcentrx Therapeutics is a biotechnology company dedicated to advancing the development of protein conjugate therapeutics aimed at treating cancer and other serious diseases. The company focuses on creating targeted therapies that leverage the precise targeting capabilities of biologics combined with the therapeutic effectiveness of small molecule payloads. Through its innovative approach, Adcentrx seeks to enhance patient treatment options, offering next-generation therapies that aim to improve outcomes for individuals facing life-threatening conditions.
SAFE Security
Series B in 2023
SAFE Security, also known as Lucideus Tech Private Limited, is a cyber risk management company headquartered in New Delhi, India. Founded in 2012, it specializes in providing comprehensive information technology risk assessment and digital security services to organizations globally. The company develops a cyber risk quantification and management platform that enables businesses to continuously monitor and respond to cyber threats in real time. SAFE Security's offerings include IT security maturity assessments, governance policy formation, application security, IT infrastructure security, and emergency response services. By establishing a common risk taxonomy, the platform facilitates better communication among stakeholders and shifts the focus of security discussions from tactical projects to strategic value, ultimately helping organizations mitigate cyber risks through prioritized actionable insights.
Aden Financial Group
Series A in 2023
Aden Financial operates a cross-border over-the-counter (OTC) assets e-trading platform designed for trading assets denominated in Chinese renminbi. The platform provides a range of services, including alternative data display, price discovery, automatic trade-matching, and click-to-trade functionalities. This comprehensive approach enables international investors, including ultra-high-net-worth individuals, family offices, and funds, to effectively invest in Greater Chinese markets and assets.
Lanzhou Technology
Seed Round in 2023
Lanzhou cognitive intelligence platform is an industrial service cloud platform with NLP as the core, providing a series of services such as a graph, machine translation, assisted writing, sentiment analysis, intelligent retrieval, intelligent customer service, document analysis, etc. Enter search, generation, translation, dialogue, and other business scenarios. They provide solutions for financial, marketing, cultural, and creative industries, focusing on the core scenarios in the industry to provide solutions to help enterprises upgrade intelligently.
TandemAI
Series A in 2023
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.
Canoe
Series B in 2023
Canoe Software Inc. provides a sophisticated software solution focused on financial document and data management. Founded in 2013 and based in New York, the company specializes in automating the extraction and organization of investment documents using artificial intelligence and machine learning technologies. This enables users to efficiently convert unstructured data from various formats, such as PDFs, into actionable insights, thereby improving operational efficiency. Canoe's platform supports a wide range of clients, including single and multi-family offices, endowments, foundations, pensions, investment consultants, and financial institutions, facilitating better management of post-investment operations, monitoring, and reporting. By streamlining the data management process, Canoe helps minimize manual data entry and enhances the accuracy of financial reporting and analysis.
NOCD
Series B in 2023
NOCD Inc. is a Chicago-based company that operates a mobile application designed to connect individuals with obsessive-compulsive disorder (OCD) to licensed mental health practitioners. Founded in 2014, the platform leverages cognitive behavioral therapy techniques, specifically exposure and response prevention exercises, to help users manage their symptoms. The application facilitates face-to-face video therapy sessions with therapists who specialize in OCD, while also providing 24/7 support through self-help tools and peer communities. NOCD aims to enhance the treatment experience for OCD patients by offering clinically supported resources and a comprehensive online platform dedicated to treatment and self-monitoring.
Enko Chem
Series C in 2023
Enko Chem, Inc. is a biotechnology company based in Woburn, Massachusetts, that focuses on discovering and developing innovative small-molecule products designed to protect crops from pests and diseases. Founded in 2017, the company utilizes a proprietary technology platform that enables the rapid identification of safe and cost-effective solutions aimed at promoting sustainable food production. Through its efforts, Enko Chem seeks to address the challenges faced by farmers in maintaining crop health while ensuring environmental sustainability.
Enzene Biosciences
Venture Round in 2023
Enzene Biosciences is a biotechnology company focused on providing affordable medicines through the development of biosimilars. The company employs advanced technologies, analytics, and a state-of-the-art manufacturing facility to enhance the efficiency of its operations. Enzene specializes in cloning, process development, and novel formulation development, which enables clients to leverage innovative solutions in commercial microbial manufacturing. By fostering strategic global alliances, Enzene aims to broaden the reach of its disruptive technologies and improve healthcare outcomes worldwide. The company is recognized for its strong workplace culture, making it an attractive employer in the biotech sector.
Cloudian
Venture Round in 2023
Cloudian is a company that specializes in file and object storage, particularly focusing on S3 object storage within data centers. It offers a hybrid cloud data management platform that allows customers to optimize data access, meet data sovereignty requirements, and reduce costs by consolidating information into a single, cloud-like environment. Cloudian's platform provides scalable and secure object storage for hybrid cloud deployments, enabling organizations to effectively manage and protect their data both on-premises and in the cloud. With its emphasis on data durability and user-friendly management tools, Cloudian aims to transform enterprise data into actionable insights while ensuring compatibility with the industry-standard S3 API.
Coho AI
Seed Round in 2023
Coho AI is a company that provides a product-led revenue platform designed to enhance the effectiveness of growth, customer success, and sales teams. Founded in 2021 and based in New York, the company leverages artificial intelligence to integrate with existing B2B SaaS tools, offering a comprehensive analysis of user interactions with products. This platform empowers businesses to make informed decisions based on user behavior data, facilitating increased upsells, expansions, and self-service conversions. By focusing on the right revenue opportunities, Coho AI aims to help teams improve conversion rates and deliver greater value to users.
MEIHUAMEDICAL
Series B in 2022
MEIHUAMEDICAL develops, produces and sells microbial medical instruments & diagnostic reagents.
Alternative Bio
Seed Round in 2022
Alternative Bio is a biotechnology company focused on developing novel therapeutics targeting a previously untapped class of post-translational modifying enzymes.
RedPine Medical
Series C in 2022
Redpine is a manufacturer of disposable medical endoscopes, specializing in single-use devices designed for minimally invasive surgical procedures. Founded in 2015 and headquartered in Guangzhou, China, the company aims to be a leading provider of integrated solutions across various medical fields, including urology, gynecology, ENT, pneumology, gastroenterology, and general surgeries. Redpine focuses on delivering advanced medical solutions that enhance detection, diagnosis, and treatment processes, supporting healthcare professionals with innovative tools to improve patient outcomes.
ABK Biomedical
Series C in 2022
ABK Biomedical Inc., founded in 2012 and based in Halifax, Canada, develops innovative embolotherapeutic products aimed at treating uterine fibroids, hypervascular tumors, and arteriovenous malformations. The company focuses on enhancing interventional radiology procedures, particularly embolization, by combining clinical market insights with advanced biomaterials. ABK Biomedical's flagship product is a novel radiopaque microsphere designed to improve the targeting of tumor blood vessels and tissue. This technology not only aids in the standardization and optimization of minimally invasive therapies but also facilitates personalized treatment options for patients with complex conditions. Through its commitment to advancing embolotherapy, ABK Biomedical seeks to transform patient care in the field of interventional radiology.
Ruiyun Cold Chain
Seed Round in 2022
Ruiyun Cold Chain is a logistics service platform in China that utilizes innovative domestic technology to offer comprehensive cold chain transportation solutions. The company provides digital, end-to-end integration services designed to optimize operational efficiency for its customers. Through its unique platform, which includes Lengyunbao—an online trading platform for carriers—and a dual-end app, Ruiyun Cold Chain facilitates smooth transactions, deliveries, settlements, and tax collection. By fostering collaboration within the cold chain network, the company effectively reduces logistics costs for cargo owners by 10% to 15%, linking industry resources with customer demand through digital intelligence.
Red Points
Venture Round in 2022
Red Points is a technology company focused on protecting brands from online counterfeiting, digital piracy, and distribution fraud. Established in 2011 and headquartered in Barcelona, Spain, Red Points offers a software-as-a-service (SaaS) platform that employs machine learning and computer vision to identify and eliminate counterfeit products and pirated content across more than one hundred online marketplaces and social networks. The platform processes hundreds of thousands of infringement incidents each month, assisting over five hundred brands globally, including well-known names such as Bang & Olufsen, MVMT, and DOPE. By providing effective solutions for brand protection, Red Points helps companies safeguard their intellectual property in the digital landscape.
Cataya Bio
Series A in 2022
Cataya Bio (Shanghai) Co., Ltd. is focused on developing synthetic biological products for diverse industries through its advanced engineering biology platform and biomanufacturing capabilities. The company engineers microbes and creates clean fermentation processes to produce high-purity products sustainably and cost-effectively. By leveraging synthetic biology technology, Cataya Bio enables clients to obtain natural and sustainable raw materials, contributing to a shift away from petroleum-based resources. The company's efforts address critical global challenges such as environmental preservation, carbon emissions, and climate change.
Elucidata
Series A in 2022
Elucidata Corporation, founded in 2015 and headquartered in New Delhi, India, specializes in accelerating drug discovery through its proprietary SaaS platform, Polly. This platform transforms drug discovery by delivering machine learning-ready biomedical molecular data, supported by a vast repository of over 230,000 multi-omic datasets, with more than 50,000 datasets added monthly. Polly curates this data semi-automatically, enabling data-driven drug discovery teams to integrate proprietary and public biomedical data for machine learning applications. By adhering to the FAIR guidelines, Polly's Data Lakes provide exclusive access to curated multi-omics data, facilitating faster identification of therapeutic assets with a higher likelihood of clinical success. The platform has proven instrumental in detecting validated drug targets across various fields, including immunology, oncology, and metabolomic disorders. Elucidata collaborates with leading organizations such as Pfizer, Agios Pharmaceuticals, and Genentech, as well as over 35 research partners from prominent biopharma companies and research institutions, enhancing decision-making processes in drug research and development.
Bhanzu
Series A in 2022
Bhanzu is a math-learning platform aimed at fostering interest in math and STEM careers among students of all ages. The platform offers a carefully crafted curriculum that caters to individual learning needs, ensuring a customized educational experience. Bhanzu provides a variety of educational resources, including videos that address common challenges such as math anxiety, particularly for younger learners in grades 1 to 3. By promoting experiential learning and enhancing cognitive abilities, Bhanzu helps students improve their math skills and apply mathematical concepts in real-world situations.
Qixiangyun
Seed Round in 2022
Qixiangyun is an innovative company in China that specializes in financial and taxation technology services. It operates the first open platform aimed at empowering Independent Software Vendors (ISVs) and terminal enterprises by providing high-quality standard components for financial and taxation systems. The platform features an intelligent financial and tax report accounting engine at its core, along with APIs and configurable functional modules that can be seamlessly integrated into various enterprise software systems. This integration allows clients to enhance their digital transformation efforts and streamline processes such as multi-enterprise and cross-regional tax declaration and deduction. By facilitating these advancements, Qixiangyun helps enterprises effectively navigate the complexities of business finance and taxation, contributing to their overall digital transformation.
InsightFinder
Series A in 2022
InsightFinder Inc. specializes in machine learning technology solutions tailored for information technology operational data. Founded in 2015 and based in Brooklyn, New York, the company offers various tools, including a metric intelligence engine for automatic anomaly detection, a log intelligence engine for real-time keyword extraction, and an alert intelligence engine designed to minimize alert fatigue by suppressing duplicate notifications. Additionally, InsightFinder provides an APM intelligence engine that identifies issues in both proprietary and third-party applications. Utilizing patented unsupervised machine learning algorithms, InsightFinder addresses complex challenges in enterprise AI and IT management, enabling organizations to automatically identify, diagnose, and remediate issues such as model drift and application failures. By focusing on predictive analytics and automated root cause analysis, InsightFinder supports large-scale AI platforms and IT infrastructures in preventing outages and enhancing overall performance.
StashAway
Series D in 2022
StashAway Malaysia Sdn Bhd is a licensed investment platform that focuses on providing accessible wealth management solutions for individuals. It caters to both retail and accredited investors by offering personalized financial planning and portfolio management services. StashAway utilizes a risk-management investment strategy known as ERAA® (Economic Regime-based Asset Allocation) to maximize long-term returns while maintaining consistent risk exposure for clients through various economic conditions. The platform aims to simplify the investment process, making it approachable for users of all experience levels, and it emphasizes low fees to enhance affordability. Through its mobile app, StashAway equips investors with the tools and resources necessary to make informed decisions, thereby facilitating effective wealth management.
Jade Bird Display
Series A in 2022
Jade Bird Display (Shanghai) Limited is a manufacturer specializing in the development and production of micro-LED display chips and panels, primarily designed for augmented reality (AR) and virtual reality (VR) applications. Founded in 2015 and headquartered in Shanghai, with an additional office in Hong Kong, the company focuses on creating the smallest, brightest, and most efficient micro-display technology. Its products are utilized in a variety of applications including head-up displays, projectors, weapon sights, 3D printing, and microscopes. By providing ultra-compact micro-display panels and light engines, Jade Bird Display enables original equipment manufacturers to enhance user comfort and outdoor readability, while also extending operating times between charges for next-generation AR and VR hardware.
Lingtan Intelligent Technology
Seed Round in 2022
Lingtan Intelligent Technology specializes in the development of innovative and sustainable distributed energy storage products and services. The company is dedicated to researching and developing hardware and software for energy storage systems, as well as virtual power plant trading platforms. It aims to deliver energy storage-based solutions tailored for various industrial and commercial sectors, including factories, commercial buildings, charging stations, and data centers. Through its focus on advanced technology, Lingtan seeks to enhance energy efficiency and sustainability in these markets.
Enko Chem
Series C in 2022
Enko Chem, Inc. is a biotechnology company based in Woburn, Massachusetts, that focuses on discovering and developing innovative small-molecule products designed to protect crops from pests and diseases. Founded in 2017, the company utilizes a proprietary technology platform that enables the rapid identification of safe and cost-effective solutions aimed at promoting sustainable food production. Through its efforts, Enko Chem seeks to address the challenges faced by farmers in maintaining crop health while ensuring environmental sustainability.
Asobica
Venture Round in 2022
Asobica, Inc. is a Japan-based company focused on the planning, development, and management of Internet businesses. It operates a platform called fever, which is designed to issue community coins and foster community engagement. Asobica aims to enhance user loyalty and corporate growth through innovative software solutions that offer features such as customer relationship management, customer analysis, and application programming interface integration. By leveraging technology and the power of the Internet, Asobica seeks to transform traditional industries and create engaging products that inspire enthusiasm and improve user experiences.
ProcessOn
Series A in 2022
ProcessOn.com is an online platform that facilitates real-time collaboration through diagramming tools. It specializes in creating various types of diagrams, including flowcharts, mockups, BPMN, UML, and mind maps, which assist users in visualizing and understanding complex concepts. The platform not only serves as a mapping tool but also functions as a social network where users can share their knowledge and completed diagrams, creating a communal knowledge base. Additionally, ProcessOn offers a product called Little Drawing Table, a visual collaboration whiteboard that enables users to brainstorm and discuss ideas in a shared digital space. This combination of tools positions ProcessOn as a valuable resource for businesses looking to enhance their collaborative processes and improve understanding of abstract information.
Kaiko
Series B in 2022
Kaiko is a provider of digital asset market data services, offering global connectivity to over 100 centralized and decentralized cryptocurrency exchanges. Its mission is to bridge traditional finance with crypto by delivering actionable financial data through four business units: Market Data, Quantitative Analytics, Indices, and Research. Kaiko empowers various use cases across the investment lifecycle for both investors and enterprises.
Gloat
Series D in 2022
Gloat is an innovative Internal Talent Marketplace that helps organizations optimize their workforce by connecting employees with suitable internal career opportunities based on their skills and career aspirations. The platform leverages artificial intelligence to provide real-time, personalized career recommendations while maintaining user anonymity. This approach allows individuals to make informed, data-driven career decisions and assists managers in identifying the best candidates for various roles. Gloat is utilized by prominent companies globally, including Unilever, PepsiCo, and HSBC, and operates in over 120 countries, enhancing organizational agility and providing valuable insights into talent management.
Changjin Biotechnology
Series A in 2022
Developer of edible microbial synthetic protein food intended to provide new form of protein sources. The company focuses on the research, development and industrialization of new microbial proteins and biosynthetic proteins, enabling clients with safe, nutritious and delicious microbial substitute protein artificial food, while lowering carbon emissions.
Spry
Series A in 2022
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.
EurekaBio
Series B in 2022
EurekaBio specializes in developing solutions for cancer immunotherapy, particularly in the realm of cell therapy. The company offers automated manufacturing equipment for cell therapies and a platform for vector production. By focusing on automation in medical equipment related to gene and cell therapy, EurekaBio aims to enhance the accuracy and efficiency of cancer treatments, ultimately benefiting patients in need of innovative therapeutic options.
Immuneel Therapeutics
Series A in 2022
Immuneel Therapeutics specializes in developing innovative cell and gene therapies for cancer treatment. The company focuses on CAR-T cell therapies, which are created by extracting blood cells from patients and genetically engineering healthy immune cells to specifically target malignant cells. This approach allows cancer patients to benefit from advanced cell-based immunotherapies that have the potential to transform their treatment outcomes.
Proximie
Series C in 2022
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.
MoEngage
Series E in 2022
MoEngage, Inc. is a cloud-based marketing and customer engagement platform founded in 2014 and headquartered in San Francisco, California, with additional offices in several international locations including India, Singapore, and the United Kingdom. The platform specializes in user analytics and engagement, offering tools for personalized interactions through various channels such as push notifications, in-app messaging, web, and SMS. It leverages machine learning to optimize customer engagement and improve retention and lifetime value for businesses across industries like e-commerce, telecom, travel, and finance. MoEngage's comprehensive dashboard enables clients to analyze customer behavior and manage campaigns efficiently, thereby enhancing their marketing efforts and attracting new customers. The company has also established a strategic partnership with Vidora, Inc. to further enhance its service offerings.
Quantstamp
Series A in 2022
Quantstamp Inc., established in 2017 and headquartered in Dover, Delaware, specializes in blockchain security. The company offers comprehensive security services, including thorough audits, protocol testing, and vulnerability assessments, ensuring the reliability and integrity of blockchain ecosystems. Its software is designed to detect and respond to suspicious activities, conducting smart contract, off-chain, networking, and front-end audits to enhance the security of decentralized applications.
Wint Wealth
Series A in 2022
Wint Wealth is a financial services company that specializes in providing high net-worth individuals and retail investors with asset-backed fixed income products designed to yield higher returns than traditional fixed deposits. By leveraging a digital investment platform, Wint Wealth democratizes access to previously exclusive investment opportunities, allowing clients to invest in high-yield asset-backed securitized debt instruments with a minimum investment as low as Rs. 10,000. This innovative approach enables investors to engage with safer investment options that typically require substantial capital, thus bridging the gap between low-risk, low-return investments and higher-yield alternatives.
BlissClub
Series A in 2022
BlissClub is a women's activewear brand focused on creating comfortable and functional apparel tailored for Indian women. The company offers a range of products, including leggings and sports bras, designed to address common challenges in women's activewear, such as fabric quality, fit, and overall functionality. By emphasizing a community-oriented approach, BlissClub aims to provide women with suitable sportswear options that can be conveniently delivered to their homes.
Invetx
Series B in 2022
Invetx, Inc. is a biotechnology company focused on developing protein-based therapeutics for animal health care and veterinary medicine. Based in Boston, Massachusetts, Invetx's team comprises veterinary scientists and clinicians dedicated to discovering and creating biotherapeutics for both pets and farm animals. The company aims to enhance health outcomes in the animal health industry by leveraging biopharma technologies, supported by a network of experts in animal and human health. Through its innovative platform, Invetx is committed to advancing a portfolio of therapies and technologies designed to improve animal care and well-being.
Toothsi
Series C in 2022
Toothsi is a dental company that offers clear aligners, an alternative to traditional braces, to gradually shift teeth into proper alignment. Toothsi's aligners are removable, invisible, and more comfortable than metal braces. Toothsi also provides oral hygiene products, teeth whitening solutions, and aligner accessories for complete oral care.
Reveal
Series A in 2022
Reveal, formerly known as Sharework, is the free platform for Partnership, Marketing, and Sales teams to generate revenue through their ecosystem. Reveal allows you to connect with companies from your ecosystem, securely compare your CRM data, and multiply up to 3X your win rate thanks to your ecosystem’s insights.
Worktile Technology
Series C in 2022
Worktile is a software-as-a-service (SaaS) platform designed to enhance enterprise work efficiency through office collaboration tools. It provides a comprehensive solution for task management, communication, and document sharing, thereby addressing the challenges of fragmented communication and management that can impede productivity. The platform enables employees to effectively collaborate by linking tasks, sharing files, and managing reports, which fosters improved internal communication. Worktile’s user-friendly interface facilitates a seamless experience, making it suitable for various work scenarios and contributing to overall organizational effectiveness.
Noogata
Series A in 2022
Noogata is an AI-powered eCommerce platform designed to provide insights and strategic guidance for consumer packaged goods (CPG) companies, digital brands, and agencies. The platform simplifies the discovery of insights, enabling eCommerce professionals to access competitive intelligence, consumer search insights, and AI tools that enhance digital shelf performance. Noogata's growth assistant monitors a vast array of products and categories, delivering actionable insights that help brands optimize their sales, advertising, and pricing strategies. By streamlining competitive data and making it easy to visualize and measure, Noogata enables its clients to outperform competitors and improve their presence in the digital marketplace. The company is supported by prominent venture capital firms, including Team8 and Eight Roads Capital.
Doceree
Series A in 2022
Doceree Inc is a healthcare marketing technology company that operates a programmatic physician engagement and advertising platform. Founded in 2019 and based in Parsippany, New Jersey, with an additional office in New Delhi, India, Doceree specializes in connecting pharmaceutical and healthcare brands with healthcare professionals (HCPs). The platform enables targeted advertising and provides data analytics to help clients effectively reach and engage with HCPs in a compliant manner. Utilizing artificial intelligence and data segmentation, Doceree identifies specific HCPs across various digital platforms, including physician networking sites, medical journals, and telemedicine platforms. This approach allows healthcare industry professionals to deliver precise and transparent messaging at scale, catering to the needs of media agencies, pharmaceutical brands, medical device companies, consumer healthcare brands, and hospitals.
Amenitiz
Series A in 2022
Amenitiz is a technology company that provides an all-in-one platform tailored for independent hoteliers. Its mission is to simplify and enhance the management of vacation properties, making it easier for hotel owners to attract guests, manage bookings, and create exceptional experiences. The platform centralizes essential tools, allowing users to build conversion-optimized websites and streamline operations. By focusing on accessibility and efficiency, Amenitiz aims to empower hoteliers worldwide, from urban centers to remote locations, ensuring they can achieve success and profitability in the competitive hospitality market.
Eleos Health
Series A in 2022
Eleos Health develops innovative health technology solutions aimed at enhancing decision-making for clinicians in the behavioral health sector. The company's AI-powered Speech-to-Insights system operates during mental health sessions to analyze voice data in real time. By gathering insights on patients through this voice technology, Eleos Health enables clinicians to deliver personalized, efficient, and cost-effective care. The automated nature of the system helps streamline the clinical process, ultimately supporting mental health professionals in providing the necessary care and support for their patients.
eKincare
Series B in 2022
eKincare is an innovative health benefits platform that leverages AI to provide personalized healthcare solutions. Recognized as India’s first personal health assistant, the platform integrates technology and analytics to deliver preventive and predictive health services to organizations and their employees. eKincare offers a variety of online and offline healthcare services, including 24/7 access to medical consultations, health check-ups, medication purchasing and delivery, health coaching, mental wellness programs, and fitness services. By monitoring and gathering medical data from various healthcare providers, the platform enables users to track their health information and identify potential health risks, facilitating timely interventions to enhance overall well-being. Trusted by numerous Fortune 500 companies, eKincare aims to redefine the healthcare experience through a comprehensive and user-friendly approach.
Tibber
Series C in 2022
Tibber is a digital electricity supplier founded in 2016 in Norway and Sweden, focusing on minimizing energy consumption and costs for its customers. The company aims to reduce residential electricity consumption for European households by 20%. Tibber operates in Sweden and Germany, serving over 100,000 homes with renewable energy at fair prices. By replacing traditional utilities with smart technology, Tibber empowers consumers to manage their energy use more effectively. Its mobile app provides real-time analytics on energy consumption and integrates with various smart home devices, promoting efficient electricity usage. Additionally, Tibber offers tech gadgets through its online store and has recently gained a license to balance the main power grid in Sweden using electric vehicles.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.